STOP-AMDR

Kenya

  • MFT Scale-Up
In Kenya, STOP-AMDR supports a phased national rollout of multiple first-line therapies, beginning in four counties. The approach introduces artesunate-pyronaridine and later rotates to dihydroartemisinin-piperaquine, while strengthening planning, provider training, reporting tools, and national malaria case-management guidance.

Key Activities

  • Quantification & Planning

    Forecasting ACT needs and planning a phased scale-up across counties.

  • Financing & Procurement

    Building the case for sustainable financing and timely access to newer ACTs.

  • Ready for Implementation

    Finalizing operational tools and preparing for the start of phased MFT deployment.

Partners

Kenya Resources

The resource library, filtered to materials relevant to Kenya.

  • STOP-AMDR Kenya Brief

    BriefEN
    View
  • Global Project Briefer

    BriefEN
    View
  • Kenya MOH MFT Implementation Plan

    GuideEN
    View
  • Kenya Malaria Specifications Catalogue

    GuidanceGuideEN
    View
  • Guidelines for the Diagnosis and Treatment of Malaria in Kenya

    GuidanceGuideEN
    View
  • Kenya Malaria Health Products and Technologies Management Handbook

    GuidanceGuideEN
    View
  • Kenya Malaria mRDT Implementation Framework

    GuideEN
    View